Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease.
J Jasper DeuringMeng LiWanlu CaoSunrui ChenWenshi WangColin de HaarC Janneke van der WoudeMaikel Petrus PeppelenboschPublished in: PloS one (2019)
Our data indicate that the PXR is a major and clinically relevant antagonist of NF-κB activity in the intestinal epithelial compartment during inflammatory bowel disease.